VRCA logo

Verrica Pharmaceuticals Inc. (VRCA)

Profile

Full Name

Verrica Pharmaceuticals Inc.

Ticker

NASDAQ: VRCA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 15, 2018

Indexes

Not included

Website

http://www.verrica.com

Employees

71

Key Details

Price

$6.61(-5.57%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$7.57M(+47.66% YoY)

Annual EPS

-$1.48(0.00% YoY)

PE ratio

-

Next earnings date

Aug 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $6.61
    VRCA price is $6.61

    30-Day Relative Volume

    0.25
    VRCA 30-day relative volume is 0.25

    Price Performance

    Price Most recent change

    -5.57%
    VRCA price was down -5.57% on Jul 25, 2025

    Price YTD change

    +844.29%
    VRCA price is up +844.29% since January 1st

    Price 1-year change

    -8.83%
    VRCA price is down -8.83% year-on-year

    Price 3-year change

    +108.52%
    VRCA price is up +108.52% over the past 3 years

    Price Range

    Price All-time high

    $23.29
    VRCA price is currently -71.62% below its historical high of $23.29

    Price 3-year low

    $0.38
    VRCA price is currently +1630.37% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $61.14M
    VRCA market capitalization is $61.14 million

    Market cap 3-year change

    +369.31%
    VRCA market capitalization is up +369.31% over the past 3 years

    Market cap All-time high

    $79.10M
    VRCA market capitalization is currently -22.71% below its historical high of $79.10 million

    Market cap sector rank

    35.53%
    VRCA market capitalization is higher than 35.53% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +117.85%
    VRCA shares outstanding is up +117.85% year-on-year

    Shares Outstanding 3-Year Change

    +125.07%
    VRCA shares outstanding is up +125.07% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.17
    VRCA beta is 0.17

    200-day SMA

    $1.10
    VRCA price is currently +500.31% above its 200-day simple moving average

    50-day SMA

    $2.04
    VRCA price is currently +224.07% above its 50-day simple moving average

    RSI

    70.73
    VRCA 14-day relative strength index is 70.73

    Volume

    0.25
    VRCA 30-day relative volume is 0.25

    ATR

    $0.77
    VRCA average true range is $0.77

    10-day Historical Volatility

    4579.28%
    VRCA 10-day historical volatility is 4579.28%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $7.57M
    VRCA annual revenue is $7.57 million

    Revenue Analysts estimate

    $19.68M
    VRCA annual revenue is currently -61.55% lower than the consensus analysts' forecast

    Revenue 1-year change

    +47.66%
    VRCA annual revenue is up +47.66% year-on-year

    Revenue Sector rank

    24.11%
    VRCA annual revenue is higher than 24.11% of companies in Healthcare sector

    EPS

    EPS

    -$1.48
    VRCA annual earnings per share is -$1.48

    EPS Analysts estimate

    -$3.33
    VRCA annual earnings per share is currently -55.49% lower than the consensus analysts' forecast

    EPS 1-year change

    0%
    VRCA annual earnings per share has remained unchanged year-on-year

    EPS Sector rank

    45.81%
    VRCA annual earnings per share is higher than 45.81% of companies in Healthcare sector

    Profit

    Gross profit

    $4.83M
    VRCA annual gross profit is $4.83 million

    Gross margin

    63.79%
    VRCA annual gross profit margin is 63.79%

    Operating profit

    -$65.84M
    VRCA annual operating income is -$65.84 million

    Operating margin

    -870.16%
    VRCA annual operating profit margin is -870.16%

    Net income

    -$76.58M
    VRCA annual net profit is -$76.58 million

    Net margin

    -1012.15%
    VRCA annual net profit margin is -1012.15%

    Expenses

    Total expenses

    $73.40M
    VRCA annual total expenses is $73.40 million

    Operating expenses

    $70.66M
    VRCA annual total operating expenses is $70.66 million

    Cost of goods sold

    $2.74M
    VRCA annual cost of goods sold is $2.74 million

    Selling, general & administrative expenses

    $58.82M
    VRCA annual SGA is $58.82 million

    Depreciation and amortization

    $1.27M
    VRCA annual depreciation & amortization is $1.27 million

    Interest expense

    $9.41M
    VRCA annual interest expense is $9.41 million

    Income tax

    -
    VRCA annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$67.17M
    VRCA annual earnings before interest & taxes is -$67.17 million

    EBITDA

    -$65.90M
    VRCA annual EBITDA is -$65.90 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $54.13M
    VRCA annual total assets is $54.13 million

    Non current assets

    $2.96M
    VRCA annual long term assets is $2.96 million

    Current assets

    $51.18M
    VRCA annual total current assets is $51.18 million

    Cash and cash equivalents

    $46.33M
    VRCA annual cash & cash equivalents is $46.33 million

    Accounts receivable

    $48.00K
    VRCA annual accounts receivable is $48.00 thousand

    Inventory

    $2.46M
    VRCA annual inventory is $2.46 million

    Liabilities

    Total liabilities

    $63.99M
    VRCA annual total liabilities is $63.99 million

    Long term liabilities

    $34.98M
    VRCA annual total long term liabilities is $34.98 million

    Current liabilities

    $29.01M
    VRCA annual total current liabilities is $29.01 million

    Accounts payable

    $1.90M
    VRCA annual accounts payable is $1.90 million

    Debt

    Total debt

    $45.94M
    VRCA annual total debt is $45.94 million

    Total debt 1-year change

    +0.94%
    VRCA annual total debt is up +0.94% year-on-year

    Long term debt

    $32.33M
    VRCA annual long term debt is $32.33 million

    Short term debt

    $13.61M
    VRCA annual short term debt is $13.61 million

    Equity & Capital

    Shareholders equity

    -$9.86M
    VRCA annual stockholders equity is -$9.86 million

    Book value

    -$9.86M
    VRCA annual book value is -$9.86 million

    Retained earnings

    -$307.03M
    VRCA annual retained earnings is -$307.03 million

    Working capital

    $22.17M
    VRCA annual working capital is $22.17 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$60.93M
    VRCA annual cash flow from operations is -$60.93 million

    Cash from operations 1-year change

    -57.94%
    VRCA annual cash flow from operations is down -57.94% year-on-year

    Cash from investing

    -$19.00K
    VRCA annual cash flow from investing activities is -$19.00 thousand

    Cash from investing 1-year change

    +94.75%
    VRCA annual cash flow from investing activities is up +94.75% year-on-year

    Cash from financing

    $37.73M
    VRCA annual cash flow from financing activities is $37.73 million

    Cash from financing 1-year change

    -49.16%
    VRCA annual cash flow from financing activities is down -49.16% year-on-year

    CAPEX

    CAPEX

    $27.00K
    VRCA annual capital expenditures is $27.00 thousand

    CAPEX 1-year change

    -92.54%
    VRCA annual capital expenditures is down -92.54% year-on-year

    Free Cash Flow

    Free cash flow

    -$60.95M
    VRCA annual free cash flow is -$60.95 million

    Free cash flow 1-year change

    -56.54%
    VRCA annual free cash flow is down -56.54% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    63.79%
    VRCA annual gross profit margin is 63.79%

    Operating margin

    -870.16%
    VRCA annual operating profit margin is -870.16%

    Net margin

    -1012.15%
    VRCA annual net profit margin is -1012.15%

    ROA & ROE

    ROA

    -112.84%
    VRCA annual return on assets is -112.84%

    ROE

    -1546.58%
    VRCA annual return on equity is -1546.58%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    VRCA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    VRCA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -3.29
    VRCA price to book ratio is -3.29

    PB ratio Sector rank

    6.45%
    VRCA price to book ratio is higher than 6.45% of companies in Healthcare sector

    PS Ratio

    PS ratio

    8.52
    VRCA price to sales ratio is 8.52

    PS ratio Sector rank

    74.13%
    VRCA price to sales ratio is higher than 74.13% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $73.97M
    VRCA enterprise value is $73.97 million

    Enterprise value Sector rank

    39.7%
    VRCA enterprise value is higher than 39.7% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.33
    VRCA EV/EBITDA is -1.33

    EV/EBITDA Sector rank

    46.21%
    VRCA EV/EBITDA is higher than 46.21% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.76
    VRCA annual current ratio is 1.76

    Quick ratio

    1.68
    VRCA annual quick ratio is 1.68

    Leverage

    Debt to equity

    -4.45
    VRCA annual debt to equity ratio is -4.45

    Interest coverage ratio

    -7.14
    VRCA annual interest coverage ratio is -7.14

    Risk & Stability

    Piotroski F-Score

    4
    VRCA piotroski f-score is 4

    Altman Z-Score

    -10.83
    VRCA altman z-score is -10.83

    Analyst ratings

    Recent major analysts updates

    May 14, 25 Needham
    Hold
    Apr 9, 25 Needham
    Hold
    Apr 8, 25 HC Wainwright & Co.
    Neutral
    Mar 12, 25 Needham
    Hold
    Dec 20, 24 Needham
    Hold
    Nov 6, 24 HC Wainwright & Co.
    Neutral
    Nov 5, 24 RBC Capital
    Sector Perform
    Nov 5, 24 Needham
    Hold
    Oct 21, 24 TD Cowen
    Buy
    Oct 4, 24 RBC Capital
    Outperform

    Institutional Ownership

    Screeners with VRCA included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks ready to break out
    Healthcare sector
    All stocks
    Stocks above analysts price target
    • What is the ticker symbol for Verrica Pharmaceuticals Inc.?
    • Does Verrica Pharmaceuticals Inc. pay dividends?
    • What sector is Verrica Pharmaceuticals Inc. in?
    • What industry is Verrica Pharmaceuticals Inc. in?
    • What country is Verrica Pharmaceuticals Inc. based in?
    • When did Verrica Pharmaceuticals Inc. go public?
    • Is Verrica Pharmaceuticals Inc. in the S&P 500?
    • Is Verrica Pharmaceuticals Inc. in the NASDAQ 100?
    • Is Verrica Pharmaceuticals Inc. in the Dow Jones?
    • When was Verrica Pharmaceuticals Inc.'s last earnings report?
    • When does Verrica Pharmaceuticals Inc. report earnings?

    What is the ticker symbol for Verrica Pharmaceuticals Inc.?

    The ticker symbol for Verrica Pharmaceuticals Inc. is NASDAQ:VRCA

    Does Verrica Pharmaceuticals Inc. pay dividends?

    No, Verrica Pharmaceuticals Inc. does not pay dividends

    What sector is Verrica Pharmaceuticals Inc. in?

    Verrica Pharmaceuticals Inc. is in the Healthcare sector

    What industry is Verrica Pharmaceuticals Inc. in?

    Verrica Pharmaceuticals Inc. is in the Biotechnology industry

    What country is Verrica Pharmaceuticals Inc. based in?

    Verrica Pharmaceuticals Inc. is headquartered in United States

    When did Verrica Pharmaceuticals Inc. go public?

    Verrica Pharmaceuticals Inc.'s initial public offering (IPO) was on June 15, 2018

    Is Verrica Pharmaceuticals Inc. in the S&P 500?

    No, Verrica Pharmaceuticals Inc. is not included in the S&P 500 index

    Is Verrica Pharmaceuticals Inc. in the NASDAQ 100?

    No, Verrica Pharmaceuticals Inc. is not included in the NASDAQ 100 index

    Is Verrica Pharmaceuticals Inc. in the Dow Jones?

    No, Verrica Pharmaceuticals Inc. is not included in the Dow Jones index

    When was Verrica Pharmaceuticals Inc.'s last earnings report?

    Verrica Pharmaceuticals Inc.'s most recent earnings report was on May 13, 2025

    When does Verrica Pharmaceuticals Inc. report earnings?

    The next expected earnings date for Verrica Pharmaceuticals Inc. is August 14, 2025
    On this page